Results 31 to 40 of about 24,300 (246)

Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia

ERJ Open Research, 2022
Aim The prevalence of monogenic disease-causing gene variants in lung transplant recipients with idiopathic pulmonary fibrosis is not fully known. Their impact on clinical outcomes before and after transplantation requires more evidence.
Christoffer Stark, Juha W. Koskenvuo, Antti Nykänen, Eija H. Seppälä, Samuel Myllykangas, Karl Lemström, Peter Raivio   +6 more
doaj   +1 more source

Using Functional Lung MRI to Predict Chronic Lung Allograft Dysfunction. [PDF]

Radiology, 2023
Fain SB, Schiebler ML.
europepmc   +3 more sources

Utility of bile acids in large airway bronchial wash versus bronchoalveolar lavage as biomarkers of microaspiration in lung transplant recipients: a retrospective cohort study

Respiratory Research, 2022
Background Bronchoalveolar lavage (BAL) is a key tool in respiratory medicine for sampling the distal airways. BAL bile acids are putative biomarkers of pulmonary microaspiration, which is associated with poor outcomes after lung transplantation ...
Chen Yang Kevin Zhang, Musawir Ahmed, Ella Huszti, Liran Levy, Sarah E. Hunter, Kristen M. Boonstra, Sajad Moshkelgosha, Andrew T. Sage, Sassan Azad, Rasheed Ghany, Jonathan C. Yeung, Oscar M. Crespin, Lianne G. Singer, Shaf Keshavjee, Tereza Martinu   +14 more
doaj   +1 more source

Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant

Frontiers in Immunology, 2021
Lung transplant patients have the lowest long-term survival rates compared to other solid organ transplants. The complications after lung transplantation such as primary graft dysfunction (PGD) and ultimately chronic lung allograft dysfunction (CLAD) are
Alexander McQuiston, Alexander McQuiston, Amir Emtiazjoo, Peggi Angel, Tiago Machuca, Jason Christie, Carl Atkinson   +6 more
doaj   +1 more source

Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients

Pathogens, 2023
Fungal infections are a significant source of morbidity in the lung transplant population via direct allograft damage and predisposing patients to the development of chronic lung allograft dysfunction.
Jesus E. Escamilla, Spenser E. January, Rodrigo Vazquez Guillamet   +2 more
doaj   +1 more source

Chronic Lung Allograft Dysfunction

Current Pulmonology Reports, 2018
Synthesize recent developments in the understanding of chronic lung allograft dysfunction (CLAD) epidemiology, pathophysiology, outcomes, and treatments with a focus on the classification of CLAD into restrictive allograft syndrome (RAS) and from bronchiolitis obliterans syndrome (BOS).
William F. Parker, Remzi Bag
openaire   +2 more sources

Update on Chronic Lung Allograft Dysfunction [PDF]

Current Transplantation Reports, 2016
Chronic lung allograft dysfunction (CLAD) encompasses a range of pathologies that cause a transplanted lung to not achieve or maintain normal function. CLAD manifests as airflow restriction and/or obstruction and is predominantly a result of chronic rejection.
Jason M, Gauthier, Ramsey R, Hachem, Daniel, Kreisel   +2 more
openaire   +2 more sources

Chronic Lung Allograft Dysfunction [PDF]

Transplantation, 2016
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans syndrome or the recently described restrictive allograft syndrome.
Royer, Pierre-Joseph, Olivera-Botello, Gustavo, Koutsokera, Angela, Aubert, John-David, Bernasconi, Eric, Tissot, Adrien, Pison, Christophe, Nicod, Laurent, Boissel, Jean-Pierre, Magnan, Antoine, Consortium, Sysclad   +10 more
openaire   +3 more sources

Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. [PDF]

, 2017
Consistent with Dr. Paul Terasaki's "humoral theory of rejection" numerous studies have shown that HLA antibodies can cause acute and chronic antibody mediated rejection (AMR) and decreased graft survival. New evidence also supports a role for antibodies
Butler, Carrie L, Reed, Elaine F, Thomas, Kimberly A, Valenzuela, Nicole M   +3 more
core   +4 more sources

The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions. [PDF]

, 2017
The 13th Banff Conference on Allograft Pathology was held in Vancouver, British Columbia, Canada from October 5 to 10, 2015. The cardiac session was devoted to current diagnostic issues in heart transplantation with a focus on antibody-mediated rejection
Angelini, A, Berry, GJ, Bruneval, P, Dragun, D, Duong Van Huyen, JP, Fedrigo, M, Haas, M, Loupy, A, Mengel, M, Miller, D, Potena, L, Reed, EF, Reinsmoen, N, Revelo, P, Smith, RN, Tebutt, S, Thum, T, West, L, Zeevi, A   +18 more
core   +1 more source